Catalent has appointed Frederic Cedrone, Ph.D., as vice president, Corporate Innovation. Cedrone will collaborate closely with Catalent’s scientific teams and external partners to leverage innovative technologies in the development of emerging therapeutic modalities.   Cedrone brings with him more than 25 years of experience in biologic drug development, including cell and gene therapies, and joins Catalent from Lysogene SA in Paris, France, where he held the role of Vice President, Alliances ...